Koyfin Home > Directory > Health Care > Alexion Pharm Inc > EBIT

Alexion Pharm Inc EBIT Chart (ALXN)

Alexion Pharm Inc annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Alexion Pharm Inc EBIT for the quarter ending September 09, 2020 was $771m a 29.23% increase of 225m year over year
  • Alexion Pharm Inc EBIT for the last 12 months ending September 09, 2020 was $2,780m a 23.02% increase of 640m year over year
  • Alexion Pharm Inc Annual EBIT for 2019 was $2,140m a 24.30% increase of 520m from 2018
  • Alexion Pharm Inc Annual EBIT for 2018 was $1,620m a 39.30% increase of 637m from 2017
  • Alexion Pharm Inc Annual EBIT for 2017 was $983m a 19.31% increase of 190m from 2016
Other Income Statement Metrics:
  • Alexion Pharm Inc EBITDA for the quarter ending December 12, 2018 was $533m a 18.12% increase of 97m year over year
  • Alexion Pharm Inc Net Income for the quarter ending December 12, 2018 was $-45m a 653.56% decrease of -294m year over year
  • Alexion Pharm Inc Total Revenue for the quarter ending December 12, 2018 was $1,129m a 17.53% increase of 198m year over year
View Chart On Koyfin

Quarterly ALXN EBIT Data

09/2020$771m
06/2020$704m
03/2020$739m
12/2019$546m
09/2019$560m
06/2019$537m
03/2019$497m
12/2018$429m
09/2018$430m
06/2018$426m

Annual ALXN EBIT Data

2019$2,140m
2018$1,620m
2017$983m
2016$793m
2015$682m
2014$916m
2013$576m
2012$400m
2011$244m
2010$151m